SCHEMBL13823409

SCHEMBL13823409

CN(c1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1)S(C)(=O)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.72
MIF P14174 1/20 0.72
PTGS1 P23219 1/20 0.72
PDE4A P27815 1/20 0.72
PDE4D Q08499 1/20 0.72
TSHR P16473 1/20 0.40
MAOB P27338 3/20 0.34
MAOA P21397 2/20 0.34
KMT2A Q03164 4/20 0.33
PTPN1 P18031 3/20 0.33
ACHE P22303 2/20 0.33
PTPN2 P17706 2/20 0.33
BRD4 O60885 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTGS2 P35354 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13815364 0.89 PTGS1 (0.69) ADORA3MIFPTGS1PDE4APDE4D
Iguratimod SCHEMBL29366981 0.84 PTGS1 (1.00) ADORA3MIFPTGS1PDE4APDE4D
SCHEMBL30753982 0.84 PTGS1 (0.77) ADORA3MIFPTGS1PDE4APDE4D
SCHEMBL31114276 0.84 PTGS1 (0.77) ADORA3MIFPTGS1PDE4APDE4D
Iguratimod SCHEMBL26326 0.84 PTGS1 (1.00) ADORA3MIFPTGS1PDE4APDE4D
Iguratimod SCHEMBL5455197 0.83 PTGS1 (0.98) ADORA3MIFPTGS1PDE4APDE4D
SCHEMBL7863101 0.80 PTGS1 (0.81) ADORA3MIFPTGS1PDE4APDE4D
Iguratimod SCHEMBL29230458 0.78 PTGS1 (0.87) ADORA3MIFPTGS1PDE4APDE4D
SCHEMBL8288071 0.78 ADORA3 (0.74) ADORA3MIFPTGS1PDE4APDE4D
SCHEMBL10417345 0.77 ACHE (0.54) ADORA3MIFPTGS1PDE4APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544711-B2 Use of nitroderivatives in urinary incontinence NICOX S.A. (FR) 2009-06-09 US disclosed
EP-1473288-B1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases NICOX SA (FR) 2008-07-16 EP disclosed